Product news

Share this article:
Teva Pharmaceuticals announced the introduction and availability of Quinapril tablets. The product is the bioequivalent to Pfizer's Accupril tablets. Quinapril tablets are available in 5 mg, 10 mg, 20 mg, and 40 mg strengths, in bottle sizes of 90 and 500.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.

Doctors back unique biosimilar names

A host of doctors has asked FDA Commissioner Margaret Hamburg to back a naming convention that would require biologics and biosimilars to have different names.

Roche has no rights to Sovaldi, panel rules

Despite a collaboration with original Sovaldi owner Pharmasset in 2004, a panel ruled Roche has no rights to HCV treatment Sovaldi.